We are monitoring the impact of COVID-19 on ADME Toxicology Testing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 9289
Share on
Share on

Global ADME Toxicology Testing Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Method, Technology, End-Users, Application, and Region – Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 9289
Pages: 160

ADME Toxicology Testing Market Size (2021 to 2026)

As per our report, the global ADME toxicology testing market size is estimated to grow a CAGR of 12.2% from 2021 to 2026.

ADME toxicology testing performance is directly dependent on the toxicity of the drug and having lower side effects with high positive results in reducing the health disorder. With increasing concern over animal rights, in vitro technology is highly recommended in almost every laboratory to have better benefits. The prediction technology is all good to have the highest growth rate in the foreseen years with varied advantages. North America is positioned first in holding the most significant shares of the global ADME toxicology testing market.


The rapid increase in several diseases and the demand for the discovery of new medicines to lower the risk of death and other effects are primarily accelerating the growth of the global ADME toxicology testing market.

The support from the government in investments to launch various new products is impacting the positive development of the global ADME toxicology testing market. The adoption of new techniques in finding a way to launch different products in significantly less time and lower side effects provides growth opportunities for the market. The reduced cost of affordable medicines by ordinary people due to ADME toxicology testing is lavishing the market's chance to grow extensively. 

The global ADME toxicology testing market receives support from technological advancements such as in silico techniques that use computer-based testing methods for faster performance to grow further. Modern cell-based assays are gaining a lot of traction worldwide, and this demand will continue to grow in the future. During the forecast period, ongoing R&D in ADME toxicology testing is expected to open up new opportunities. North America currently has the largest share of the global ADME toxicology testing market, and it is projected to continue to do so in the future.


However, fluctuations in the availability of raw materials are hampering the growth of the market. The increasing prices of pharmaceutical products and violations in following rules and regulations by agencies are challenging factors in the global ADME toxicology testing market.

Several of these techniques require advanced knowledge and software that can manage and store large volumes of data quickly, lack of in-vitro models to detect autoimmunity and immune stimulation might restrict market expansion to some extent. Furthermore, the market's growth is likely to be hampered by a shortage of efficient software to manage automated robotic arms and liquid handling systems. In the United States, the COVID-19 outbreak has been growing at an exponential rate. This has resulted in a decrease in the number of daily patient visits to hospitals and clinics and a decrease in the number of profiling studies performed under normal conditions. To some extent, this is expected to stifle the global ADME toxicology testing market growth.

High research costs and strict government rules and regulations associated with ADME toxicology testing, on the other hand, are major challenges to the market's expansion. A lack of understanding of the underlying scientific principles and the proper technique selection results in various direct and indirect costs. As a result, highly skilled personnel are required to create, validate, service, and troubleshoot. These are the challenges faced by the ADME toxicology Testing Market.

COVID-19 impact on the global ADME toxicology testing market:

Health supplies and equipment are at risk of running out due to the rapid spread of COVID-19. COVID-19 hasn't had a significant effect on raw material supplies for toxicology technologies, aside from transportation delays caused by travel restrictions and some driver shortage problems. The demand for toxicology technologies, especially diagnostic assays and PCR, has increased, with the demand for faster testing and research in the field. Various diagnostic kits, such as PCR testing panels and medications, have been licensed by the FDA for emergency use in COVID -19 testing and diagnostics. The ADME Toxicology Screening System is an interactive workstation that defines the properties of drug molecules in terms of absorption, distribution, metabolism, and excretion. Furthermore, due to the widespread outbreak of coronavirus disease (COVID-19) and the lack of an effective vaccine or treatment, ADME toxicology testing is being used to assess existing drugs' efficacy as an alternative treatment is increasing market growth.




Market Size Available

2020 to 2026

Base Year


Forecast Period

2021 to 2026

Segments Covered

Based on the Method, Technology, End-Users, Application, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa


This research report on the global ADME toxicology testing market has been segmented and sub-segmented based on the method, technology, application, end-user, and region.

ADME Toxicology Testing Market – By Method:

  • Cellular Assay
  • Biochemical Assay
  • In Silica
  • Ex-vivo

The cellular assay segment is expected to occupy a substantial share in the global ADME toxicology testing market based on the product. Factors such as accurate, highly detailed methods are the reason for segment growth. These assays don’t eliminate clinical experiments, but they make human research successful with less risky action to achieve better results.

ADME Toxicology Testing Market – By Technology:

  • Cell Culture
  • High Throughput
  • Molecular Imaging
  • OMICS Technology

Based on technology, Cell Culture technology to have a dominant share in the global ADME toxicology testing market. From 2D cell culture to 3D cell culture, the transformation is completed where 3D shows the visual result and the skill to test in lower volumes.

ADME Toxicology Testing Market – By Application:

  • Systemic Toxicity
  • Renal Toxicity
  • Hepatotoxicity
  • Neurotoxicity
  • Others

Based on the application, Systemic toxicity held a prominent market share. It continued its power and influence throughout the period due to the upward or forward movement in Cardiology's toxicity studies. Systemic toxicity continues to have its power and influence throughout the period. It is the most chosen drug distribution method, which is also one of the crucial causes of toxic reactions. Renal and Hepatotoxicity are the major applications to witness rapid growth in the future.

ADME Toxicology Testing Market – By End-Users:

  • Hospitals and clinics
  • Diagnostic centers
  • Pathological Labs
  • Others

ADME Toxicology Testing Market – By Region:

  • North America
    • The U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Rest of EU
  • Asia-Pacific
    • India
    • China
    • Japan
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Chile
    • Rest of Latin America
  • Middle East
  • Africa

Geographically, the global ADME toxicology testing market is looking forward to a steady pace throughout the forecast timespan. North American ADME Toxicology Testing Market is positioned first in holding the highest shares of the global market. The quick adoption of the latest technologies and maintaining strict management rules by the government propel the market demand in this region.

The Asia Pacific and Europe regions are to have dominant shares shortly. Changes in the policies favoring pharmaceutical companies and the growing number of research institutes help the market grow.


Some of the noteworthy companies dominating the global ADME toxicology testing market profiled in this report are Promega Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Cellartis AB, Cyprotex PLC., Life Technologies Corporation, Optivia Biotechnology, Inc., Accelrys, Inc., Molecular Discovery Ltd., Cyprotex PLC and MultiCASE, Inc.


  • In February 2020, QLinea AB announced that the company had made a partnership with Thermo Fischer scientific to commercialize ASTar. 
  • In February 2020, TFS introduced the IonTorrent CarrierSeq ECS Kit for expanding their careers.  
  • In February 2020, Thermo Fisher collaborated with the NanoPin diagnostic platform for rapid and quantified results from patient blood-based infectious disease detection technology through the development of liquid chromatography-mass spectrometry (LC-MS) based workflows. 
  • In January 2020, TFS launched the next-generation compressor-free plate sealer at SLAS 2020.  
  • In November 2019, TFS launched the latest Forensic Qualified, an affordable and easy-to-use capillary electrophoresis platform. 
  • In October 2019, Arctoris announced a partnership with Molecule to tackle the ongoing crisis. Actors made the researchers and biotechnological entrepreneurs design and executed advanced cell-based and molecular biology through its automated drug discovery platform.  
  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Method
      1. Cellular Assay
      2. Biochemical Assay
      3. In Silica
      4. Ex-vivo
      5. Y-o-Y Growth Analysis, By Method
      6. Market Attractiveness Analysis, By Method
      7. Market Share Analysis, By Method
    2. By Technology
      1. Cell Culture
      2. High Throughput
      3. Molecular Imaging
      4. OMICS Technology
      5. Y-o-Y Growth Analysis, By Technology
      6. Market Attractiveness Analysis, By Technology
      7. Market Share Analysis, By Technology
    3. By Application
      1. Systemic Toxicity
      2. Renal Toxicity
      3. Hepatotoxicity
      4. Neurotoxicity
      5. Others
      6. Y-o-Y Growth Analysis, By Application
      7. Market Attractiveness Analysis, By Application
      8. Market Share Analysis, By Application
    4. By End Users
      1. Hospitals and clinics
      2. Diagnostic centers
      3. Pathological Labs
      4. Others
      5. Y-o-Y Growth Analysis, By End Users
      6. Market Attractiveness Analysis, By End Users
      7. Market Share Analysis, By End Users
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Product
        3. By Technology
        4. By Application
        5. By End-User
      4. Market Attractiveness Analysis      
        1. By Geographical Area
        2. By Product
        3. By Technology
        4. By Application
        5. By End-User
      5.      Market Share Analysis   
        1. By Geographical Area
        2. By Product
        3. By Technology
        4. By Application
        5. By End-User
    2. North America
      1. Introduction
      2. US
      3. Canada
    3. Europe
      1. Introduction
      2. UK
      3. France
      4. Spain
      5. Germany
      6. Italy
    4. Asia-Pacific
      1. Introduction
      2. India
      3. China
      4. Japan
      5. South Korea
      6. Australia
    5. Latin America
      1. Introduction
      2. Brazil
      3. Argentina
      4. Mexico
    6. Middle East & Africa
      1. Introduction
      2. Middle East
      3. Africa
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Promega Corporation
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Agilent Technologies, Inc.
    3. Thermo Fisher Scientific, Inc.
    4. Bio-Rad Laboratories, Inc.
    5. Beckman Coulter, Inc.
    6. Cellartis AB
    7. Cyprotex PLC.
    8. Life Technologies Corporation
    9. Optivia Biotechnology, Inc.
    10. Accelrys, Inc.
    11. Molecular Discovery Ltd.
    12. Cyprotex PLC
    13. MultiCASE, Inc.
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures 
  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of method, technology, application and end-user  along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

ADME Toxicology Testing Market

ADME Toxicology Testing Market

Please wait. . . . Your request is being processed

Related Reports


$ 1234 4255

Click for Request Sample